跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 66 条关于
“HDFN”
全部
66
临床试验
48
药物
6
机构
0
资讯
12
2年前
Nipocalimab Shows Promise in Preventing Hemolytic Disease of the Fetus and Newborn
去年
Johnson & Johnson Halts Rheumatoid Arthritis Trial for Nipocalimab, Refocuses on Rare Disease Markets
去年
Nipocalimab Receives FDA Breakthrough Therapy Designation for Sjögren's Disease
2年前
J&J's Nipocalimab Shows Promise in Treating Autoimmune Diseases
去年
Nipocalimab Granted FDA Breakthrough Therapy Designation for Sjögren’s Disease
去年
Nipocalimab Receives FDA Breakthrough Therapy Designation for Sjögren’s Disease
去年
Nipocalimab Granted FDA Breakthrough Therapy Designation for Sjögren's Disease
10个月前
Nipocalimab Demonstrates Significant Efficacy in Phase 2 Sjögren's Disease Trial Published in The Lancet
去年
John Gorman's Anti-D Breakthrough Eradicates Rh Disease in Developed World
去年
Nipocalimab Receives FDA Breakthrough Therapy Designation for Sjögren's Disease
第 1 页,共 2 页
上一页
下一页